|
Volumn 33, Issue 3, 2001, Pages 2232-2233
|
Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
TACROLIMUS;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
METHODOLOGY;
MULTICENTER STUDY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ADRENAL CORTEX HORMONES;
CYCLOSPORINE;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
METHYLPREDNISOLONE;
TACROLIMUS;
TIME FACTORS;
|
EID: 0035345106
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02065-6 Document Type: Article |
Times cited : (4)
|
References (3)
|